Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Frey

Showing results (731-740 of 890) with videos related to

Pageof 89
Sort By:
Neurology|May 10, 2000
Decreased striatal monoaminergic terminals in Huntington diseaseN I Bohnen, R A Koeppe, P Meyer, et al.
Behavioural Brain Research|September 21, 2011
Postmenopausal hormone use impact on emotion processing circuitryTal Shafir, Tiffany Love, Alison Berent-Spillson, et al.
Nanotechnology|January 11, 2014
Exchange bias effect in Au-Fe3O4 nanocompositesSayan Chandra, N A Frey Huls, M H Phan, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 1, 1996
Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporterR A Koeppe, K A Frey, T M Vander Borght, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1991
Scintigraphic portrayal of beta receptors in the heartJ C Sisson, D M Wieland, R A Koeppe, et al.
Brain Communications|December 26, 2022
Progression of regional cortical cholinergic denervation in Parkinson's diseaseNicolaas I Bohnen, Stiven Roytman, Prabesh Kanel, et al.
Neurology|November 17, 2019
Apathy rating scores and β-amyloidopathy in patients with Parkinson disease at risk for cognitive declineZhi Zhou, Martijn L T M Müller, Prabesh Kanel, et al.
Neurology|October 1, 2013
Gait speed in Parkinson disease correlates with cholinergic degenerationNicolaas I Bohnen, Kirk A Frey, Stephanie Studenski, et al.
JAMA Neurology|December 16, 2014
Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effectsNicolaas I Bohnen, Roger L Albin, Martijn L T M Müller, et al.
Cell|July 18, 1986
Two human 35 kd inhibitors of phospholipase A2 are related to substrates of pp60v-src and of the epidermal growth factor receptor/kinaseK S Huang, B P Wallner, R J Mattaliano, et al.
Pageof 89

Showing results (731-740 of 890) with videos related to

Sort By:
Pageof 89
Neurology|May 10, 2000
Decreased striatal monoaminergic terminals in Huntington diseaseN I Bohnen, R A Koeppe, P Meyer, et al.
Behavioural Brain Research|September 21, 2011
Postmenopausal hormone use impact on emotion processing circuitryTal Shafir, Tiffany Love, Alison Berent-Spillson, et al.
Nanotechnology|January 11, 2014
Exchange bias effect in Au-Fe3O4 nanocompositesSayan Chandra, N A Frey Huls, M H Phan, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 1, 1996
Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporterR A Koeppe, K A Frey, T M Vander Borght, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1991
Scintigraphic portrayal of beta receptors in the heartJ C Sisson, D M Wieland, R A Koeppe, et al.
Brain Communications|December 26, 2022
Progression of regional cortical cholinergic denervation in Parkinson's diseaseNicolaas I Bohnen, Stiven Roytman, Prabesh Kanel, et al.
Neurology|November 17, 2019
Apathy rating scores and β-amyloidopathy in patients with Parkinson disease at risk for cognitive declineZhi Zhou, Martijn L T M Müller, Prabesh Kanel, et al.
Neurology|October 1, 2013
Gait speed in Parkinson disease correlates with cholinergic degenerationNicolaas I Bohnen, Kirk A Frey, Stephanie Studenski, et al.
JAMA Neurology|December 16, 2014
Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effectsNicolaas I Bohnen, Roger L Albin, Martijn L T M Müller, et al.
Cell|July 18, 1986
Two human 35 kd inhibitors of phospholipase A2 are related to substrates of pp60v-src and of the epidermal growth factor receptor/kinaseK S Huang, B P Wallner, R J Mattaliano, et al.
Pageof 89